May CPI and Housing...
Health Care: Drugs
Targacept Inc. (TRGT: NASDAQ)
$4.89 0.08 | 1.66%
06/18/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 82.24M | 107.28M | 165.85M | 83.91M |
| Receivables | 1.38M | 218.00K | 838.00K | 201.80M |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 1.40M | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 127.74M | 198.69M | 218.08M | 314.43M |
| Property, Plant & Equipment, Gross | 5.51M | 17.87M | 17.95M | 14.83M |
| Accumulated Depreciation & Depletion | 3.87M | 12.83M | 11.88M | 10.05M |
| Property, Plant & Equipment, Net | 1.64M | 5.04M | 6.07M | 4.78M |
| Intangibles | 115.00K | 132.00K | 149.00K | 167.00K |
| Other Non-Current Assets | 60.08M | 54.27M | 38.49M | 0.00 |
| Total Non-Current Assets | 61.84M | 59.43M | 44.71M | 4.95M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 189.58M | 258.13M | 262.79M | 319.38M |
| Accounts Payable | 2.06M | 3.49M | 4.72M | 17.28M |
| Short Term Debt | 851.00K | 1.24M | 1.71M | 1.44M |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 11.35M | 78.61M | 98.66M | 101.16M |
| Long Term Debt | 1.14M | 1.99M | 1.35M | 1.97M |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 1.18M | 3.24M | 70.93M | 147.26M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 2.32M | 5.23M | 72.28M | 149.23M |
| Total Liabilities | 13.66M | 83.84M | 170.94M | 250.39M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 175.92M | 174.29M | 91.85M | 68.99M |
| Common Par | 34.00K | 33.00K | 29.00K | 28.00K |
| Additional Paid In Capital | 409.61M | 401.15M | 309.99M | 298.26M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -233.93M | -226.93M | -218.40M | -229.30M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 201.00K | 36.00K | 225.00K | 0.00 |
| Total Capitalization | 177.05M | 176.27M | 93.20M | 70.96M |
| Total Equity | 175.92M | 174.29M | 91.85M | 68.99M |
| Total Liabilities & Stock Equity | 189.58M | 258.13M | 262.79M | 319.38M |
| Total Common Shares Outstanding | 33.62M | 33.38M | 28.87M | 28.23M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 33.48M | 31.64M | 28.54M | 25.64M |
| Diluted Weighted Shares Outstanding | 33.48M | 31.64M | 30.15M | 25.64M |
| Number of Employees | 40 | 142 | 132 | 116 |
| Number of Part-Time Employees | 1 | 0 | 0 | 0 |
Portfolios with TRGT
- Portfolio NameUser Type
- UserGFNN Stockdiagnostics 29
- Userjobeco
- UserFirstval
- UserGFNN Stockdiagnostics 10
- UserMiriam Hoath
- ContributorStocks Under-$10 Setting Up...
- Contributor10 Biotech Stocks Loved and...
- ContributorHot Biotech Trades for Seco...
- UserMoney
- UserBVF Inc.
Latest TRGT Headlines from TheStreet
- Three Cheers For Alkermes Running A Depression Study In The US of A 04.17.13 | 10:04 am
- 7 Biotechnology Stocks With Insider Buying Activity 03.20.13 | 10:03 am
- 10 Biotech Stocks With A History Of Beating Earning Expectations 01.10.13 | 07:01 pm
- The Twitterverse's Biotech Stock Picks for 2013 01.02.13 | 08:01 am
- Insider Trading TPCA JCP TRGT GLW 11.20.12 | 10:11 am
- The Targacept Secret That Wall Street Doesn't Want You to Know About 09.18.12 | 07:09 am
- Targacept Stock Hits New 52-Week Low (TRGT) 05.18.12 | 10:05 am
- Targacept Stock Hits New 52-Week Low (TRGT) 04.09.12 | 12:04 pm
- Targacept Stock Gaps Down On Today's Open (TRGT) 03.20.12 | 10:03 am
- Stocks to Watch: Tiffany, Adobe, Targacept (Update 1) 03.20.12 | 08:03 am
Press Releases for TRGT
- Targacept Announces Changes To Board Of Directors And Management - Business Wire 03.18.13 | 04:03 pm
- Targacept And AstraZeneca Amend Collaboration - Business Wire 03.05.13 | 07:03 am
- Targacept To Present At The Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.26.13 | 08:02 am
- Targacept Reports Fourth Quarter And 2012 Financial Results - Business Wire 02.13.13 | 04:02 pm
- Targacept To Report Fourth Quarter And 2012 Financial Results On February 13, 2013 - Business Wire 02.06.13 | 08:02 am
- Targacept To Present At The 15th Annual BIO CEO & Investor Conference - Business Wire 02.04.13 | 08:02 am
- Targacept To Present At The 2012 Deutsche Bank DbAccess BioFEST - Business Wire 11.27.12 | 08:11 am
- Targacept Appoints Stephen A. Hill, M.D., President And Chief Executive Officer - Business Wire 11.15.12 | 08:11 am
- Targacept Reports Third Quarter 2012 Financial Results - Business Wire 11.06.12 | 04:11 pm
- Targacept To Report Third Quarter 2012 Financial Results On November 6, 2012 - Business Wire 11.01.12 | 08:11 am
Partner Headlines for TRGT
- Targacept Completes Recruitment in Phase 2b Schizophrenia Trial of TC-5619 - Benzinga 04.18.13 | 09:04 am
- 5 Beaten Up Stocks That Insiders Think Can Rebound - Seeking Alpha 04.13.13 | 09:04 am
- Insider Buying Trends: Are These Cash Rich Companies Ready To Rally? - Seeking Alpha 03.15.13 | 09:03 am
- Targacept Says Hill Named CEO - Benzinga 11.15.12 | 08:11 am
- Targacept's ADHDi Candidate Fails - Analyst Blog - NASDAQ 09.20.12 | 10:09 pm
- Targacept's ADHDi Candidate Fails - Analyst Blog - Zacks 09.20.12 | 06:09 pm
- Morning Market Losers - Benzinga 09.17.12 | 09:09 am
- Healthcare Business Review: Vivus DISSED By Citron, Lundbeck, et al Have OPPORTUNITY - Wall St. Cheat Sheet 07.20.12 | 08:07 am
- Why Should You Invest Only in High-Quality Companies? - GuruFocus 06.14.12 | 08:06 pm
- Morning Market Losers - Benzinga 03.20.12 | 09:03 am
